Company Analysis Tekla Healthcare Investors
1. Summary
Advantages
- Price (15.62 $) is less than fair price (18.9 $)
- Dividends (13.22%) are higher than the sector average (2.95%).
- The company's current efficiency (ROE=18.58%) is higher than the sector average (ROE=16.52%)
Disadvantages
- The stock's return over the last year (-17.53%) is lower than the sector average (0%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Tekla Healthcare Investors | Financials | Index | |
---|---|---|---|
7 days | -1.5% | 0% | 0% |
90 days | 5% | -7.3% | 17.7% |
1 year | -17.5% | 0% | 11.4% |
HQH vs Sector: Tekla Healthcare Investors has significantly underperformed the "Financials" sector by -17.53% over the past year.
HQH vs Market: Tekla Healthcare Investors has significantly underperformed the market by -28.98% over the past year.
Stable price: HQH is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: HQH with weekly volatility of -0.3371% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (15.62 $) is lower than the fair price (18.9 $).
Price significantly below the fair price: The current price (15.62 $) is 21% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (5.25) is lower than that of the sector as a whole (63.39).
P/E vs Market: The company's P/E (5.25) is lower than that of the market as a whole (61.84).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.9161) is lower than that of the sector as a whole (2.7).
P/BV vs Market: The company's P/BV (0.9161) is lower than that of the market as a whole (20.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (90.13) is higher than that of the sector as a whole (3.95).
P/S vs Market: The company's P/S indicator (90.13) is higher than that of the market as a whole (15.97).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (13.69) is higher than that of the sector as a whole (-120.2).
EV/Ebitda vs Market: The company's EV/Ebitda (13.69) is lower than that of the market as a whole (18.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -4.66% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-4.66%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-52.19%).
5.4. ROE
ROE vs Sector: The company's ROE (18.58%) is higher than that of the sector as a whole (16.52%).
ROE vs Market: The company's ROE (18.58%) is lower than that of the market as a whole (42.62%).
5.5. ROA
ROA vs Sector: The company's ROA (18.56%) is higher than that of the sector as a whole (3.56%).
ROA vs Market: The company's ROA (18.56%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (5.17%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.15%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 13.22% is higher than the average for the sector '2.95%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 13.22% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 13.22% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription